Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Disease and patient characteristics in NP-C patients: findings from an international disease registry

  • 1, 8Email author,
  • 2,
  • 3,
  • 4,
  • 4,
  • 5,
  • 6 and
  • 7
Orphanet Journal of Rare Diseases20138:73

https://doi.org/10.1186/1750-1172-8-73

  • Received: 7 May 2013
  • Accepted: 7 May 2013
  • Published:

The original article was published in Orphanet Journal of Rare Diseases 2013 8:12

Correction

After the publication of this work [1] it was brought to the authors attention that Figure 1 contained an inversion in the color of the triangles, where yellow which should be "diagnosis" is said to be "first miglustat use", and blue which should be " first miglustat use" is said to be " diagnosis". The correct figure is given below:
Figure 1
Figure 1

Overview of patient and disease characteristics. We regret any inconvenience that this inaccuracy may have caused.

Notes

Declarations

Authors’ Affiliations

(1)
Mayo Clinic, Rochester, MN, USA
(2)
Villa Metabolica, ZKJM, MC, University of Mainz, Mainz, Germany
(3)
Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
(4)
Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
(5)
Numerus Ltd, Wokingham, UK
(6)
INSERM Unit 820, Lyon, France
(7)
Fundació Hospital Sant Joan de Déu, Barcelona, Spain
(8)
Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

References

  1. Patterson MC, Eugen M, Wijburg FA, Audrey M, Barbara S, Harir D, Vanier MT, Mercé P: Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet Journal of Rare Diseases. 2013, 8: 12-10.1186/1750-1172-8-12.PubMed CentralPubMedView ArticleGoogle Scholar

Copyright

Advertisement